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Available online 4 August 2016Background: Transfusion of blood at the limits of approved storage time is associated with lower red blood cell
(RBC) post-transfusion recovery and hemolysis, which increases plasma cell-free hemoglobin and iron, proposed
to induce endothelial dysfunction and impair host defense. There is noted variability among donors in the intrin-
sic rate of storage changes and RBC post-transfusion recovery, yet genetic determinants that modulate this pro-
cess are unclear.
Methods:We explore RBC storage stability and post-transfusion recovery inmurine models of allogeneic and xe-
nogeneic transfusion using blood from humanized transgenic sickle cell hemizygous mice (Hbatm1PazHbb-
tm1TowTg(HBA-HBBs)41Paz/J) and human donors with a common genetic mutation sickle cell trait (HbAS).
Findings:Human and transgenic HbAS RBCs demonstrate accelerated storage time-dependent hemolysis and re-
duced post-transfusion recovery inmice. The rapid post-transfusion clearance of stored HbAS RBC is unrelated to
macrophage-mediated uptake or intravascular hemolysis, but by enhanced sequestration in the spleen, kidney
and liver. HbAS RBCs are intrinsically different from HbAA RBCs, with reduced membrane deformability as
cells age in cold storage, leading to accelerated clearance of transfused HbAS RBCs by entrapment in organmicro-
circulation.
Interpretation: The commongenetic variant HbAS enhances RBC storage dysfunction and raises provocative ques-
tions about the use of HbAS RBCs at the limits of approved storage.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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RBC hemolysis1. Introduction
Sickle cell trait is the carrier status of sickle cell disease (SCD), a se-
vere hemolytic disease that is caused by a point mutation in the gene
encoding beta-hemoglobin (β6Glu→ Val) that increases the hydropho-
bicity of this protein when deoxygenated. In SCD RBCs, this mutation
causes Hb polymerization under small reductions in physiologic oxygenBlood and Vascular Medicine
Care Medicine, Department of
p Street, Pittsburgh, PA 15213,
upmc.edu (M.T. Gladwin).
. This is an open access article undersaturation leading to cell dehydration, increasedmembrane rigidity and
hemolysis (Rees et al., 2010; Brittenham et al., 1985). These altered red
cell properties promote vaso-occlusive events inmicrocirculation, caus-
ing severe pain and end-organ ischemia, infarction and progressive
dysfunction. Red blood cells (RBCs) from individuals with sickle cell
trait (SCT) contain 25–50% HbS that polymerizes only at low fractional
oxygen saturations b50% (Brittenham et al., 1985). Thus, under normal
physiologic conditions, individuals with sickle cell trait are asymptom-
atic. However, under extreme conditions of hypoxia and dehydration,
vaso-occlusive events can occur (Statius van Eps and De Jong, 1997).
Historically, donor RBC genetic background is considered benign if
the donor lacks clinically relevant symptoms but prolonged storage
exposes RBCs to non-physiologic stress conditions and may amplify
the effects of occult mutations (Dern et al., 1967; Latham et al., 1982).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
240 D.O. Osei-Hwedieh et al. / EBioMedicine 11 (2016) 239–248Sickle cell trait has a high prevalence inmalaria endemic regions, which
increases the probability that patients requiring RBC transfusions in
these regions will receive stored HbAS RBCs. Current transfusion prac-
tices supporting the use of sickle cell trait RBCs are based on limited
studies performed decades ago, which reported no differences in post-
transfusion survival or recovery of sickle trait RBCs comparedwith nor-
mal RBCs. However, storage duration was relatively short (b21 days
comparedwith present 42-day storage limits) and utilized less sensitive
methods to evaluate RBC post-transfusion survival (Callender et al.,
1949; Ray et al., 1959; Levin and Truax, 1960). Here,we show that sickle
cell trait increases storage hemolysis and reduces red cell post-transfu-
sion survival in mice, an effect that increases with increasing time in
storage. Interestingly, transfusedHbAS RBCs do not exhibit higher intra-
vascular hemolysis compared to HbAA RBCs, but rather become
entrapped in the systemic microcirculation. These ﬁndings raise con-
cerns about the viability of stored sickle cell trait red blood cells after
prolonged storage and suggest a need for further clinical evaluation of
post-transfusion recovery of stored human HbAS containing RBCs.2. Materials and Methods
2.1. Mice
8–12 week old wildtype (HbAA) mice (C57BL/6J), Berkeley hemizy-
gous (HbAS) (Hbatm1PazHbbtm1TowTg(HBA-HBBs)41Paz/J) mice and
transgenic mice expressing enhanced Green Fluorescent Protein in he-
matopoietic cells (C57BL/6-Tg(UBC-GFP)30Scha/J) were purchased
from Jackson Laboratories. Berkeley hemizygous mice express human
α-globin and sickleβ-globin genes in addition to one copy of themurine
β-globin, making them hemizygous for Sickle Cell Disease (HbAS). Our
characterization studies and those of others suggest these mice express
20–30% HbS, which is similar to the 20–45% HbS distribution observed
in sickle cell trait individuals (Noguchi et al., 2001; Steinberg and
Embury, 1986). Procedures involving animals were approved by the In-
stitutional Animal Care and Use Committee of the University of Pitts-
burgh. Both male and female mice were used as donors for RBC
isolation. Recipient male mice were of C57Bl/6J strain and randomly
assigned to experimental groups to receive either HbAA or HbAS
blood. Experimenters performing the experiments was not blinded to
group assignment but was blinded to outcome assessment. There was
no exclusion of data from any animals.2.2. Blood Collection and Storage
Leukoreduced human RBC units were stored under standard blood
banking conditions from sickle cell trait donors and ABO blood type
matched donors were obtained from Central Blood Bank (Pittsburgh,
PA) and stored at 1–6 °C until speciﬁed times for testing. Whole blood
(WB) was collected from mice via the inferior vena cava immediately
following euthanasia using Citrate Phosphate Dextrose solution as an
anti-coagulant (Sigma St. Louis, MO). Pooled WB from mice and
human blood was leukoreduced using a Pall Purecell® NEO Neonatal
High Efﬁciency Leukocyte Reduction Filter (Hod et al., 2010b).
Leukoreduced blood was re-suspended in 14% CPDA-1 (Sigma St.
Louis, MO), concentrated to a ﬁnal hematocrit of 55%, and stored at
1–6 °C in glass vacutainers shielded from light for up to 11 days (Hod
et al., 2010b).2.3. In Vitro Hemolytic Assays
Storage hemolysis and stress-induced osmotic or mechanical
hemolysis were measured by supernatant cell-free hemoglobin using
Drabkin's assay (Moore et al., 1995). See Supplemental section.2.4. Post-Transfusion Survival Studies
Fresh or 11-day storedmurine RBCs (equivalent to 39–42 day stored
human RBCs) (Mangalmurti et al., 2009; Gilson et al., 2009) for transfu-
sion were labeled with lipophilic dyes 1,1′-dioctadecyl-3,3,3′3′-
tetramethylindocarbocyanine perchlorate dyes DiI (D-383) or DiD (D-
307) (Invitrogen, Carlsbad CA) prior to infusion in recipient mice by
retro-orbital injection. RBC 24 h post-transfusion recoverywas obtained
by blood sampling via tail vein and enumerated by ﬂow cytometry and
analyzed using FlowJo (Ashland, OR). To conﬁrm that ﬂuorescent label-
ing dyes do not alter RBC post-transfusion survival, C57BL/6 mice
expressing Green Fluorescent Protein (GFP) driven by the human ubiq-
uitin C promoter (C57BL/6-Tg (UBC-GFP) 30Scha/J) were transfused
with unlabeled fresh or stored HbAA and HbAS RBCs individually and
analyzed using a negative FITC gate to quantify 24 h post-transfusion
recovery.
2.5. Statistical Methods
To measure storage-related changes between HbAA and HbAS RBCs
such as echinocyte formation, changes in hemolytic propensity and
post-transfusion survival, two-way ANOVA with Bonferroni post-test
for individual comparisons was used to perform statistical analysis. To
determine differences in HbAA and HbAS RBC sequestration in tissues,
Mann-Whitney U test was used for non-parametric analysis (GraphPad
Prism 6, La Jolla, CA). Initial pilot studies examining RBC post-transfu-
sion recovery provided the basis for sample size estimation of recipient
mice. Details regarding statistics, technical and biological replicates per-
formed are provided in the Figure Legends.
3. Results
3.1. HbAS Red Blood Cells Exhibit Higher Storage Hemolysis, Increased
Resistance to Osmotic Stress
To assess the membrane properties of HbAA and HbAS RBCs, con-
ventionally banked human and murine RBCs stored in standard preser-
vative solution were assayed at the beginning and end of storage.
Human RBCs under standard blood banking can be stored up to
42 days (Koch et al., 2008). Leukoreduced murine RBCs stored for up
to 14 days show post-transfusion recovery that approximates what is
observedwith humanRBCs at the limits of approved storage, suggesting
that these shorter storage times represent a more appropriate and con-
servative model for day 39–42 human RBC storage (Hod et al., 2010b;
Gilson et al., 2009). By 39–42 days of storage, conventionally banked
human HbAS (h-HbAS) RBCs exhibited higher storage hemolysis com-
pared to human HbAA (h-HbAA) RBC samples (1.0 ± 0.6% versus
0.15 ± 0.02%, p = 0.0035, Fig. 1a). RBCs from Berkeley hemizygous
mice (m-HbAS) also exhibited higher storage hemolysis at the end of
11-day storage compared to murine HbAA (m-HbAA) RBCs (2.4 ±
0.16% versus 1.7±0.1%, p=0.0022, Fig. 1b). In both human andmurine
HbAS RBCs, free hemoglobin concentrations were higher at the begin-
ning of storage compared to HbAA RBCs, a transient increase likely
due to mechanical challenges suffered during leukoreduction (Fig. 1a–
b) (Stroncek et al., 2002). The size distribution and hemoglobin content
of human HbAA and HbAS RBCs showed no differences (Supplemental
Fig. S1).
To determine membrane resilience to osmotic shock, packed RBCs
were re-suspended in a hypotonic buffer for 3 h. Similar to prior ﬁnd-
ings in HbSS RBCs,(Franco et al., 2000) human and murine HbAS RBCs
showed reduced % osmotic hemolysis, or increased resilience to osmotic
shock, compared with HbAA RBCs (h-HbAS and h-HbAA RBCs: 9.0 ±
3·1% vs. 35.1 ± 10.3% hemolysis; p b 0.0001, Fig. 1c; m-HbAS and
m-HbAA RBCs: 18.1 ± 5.4% vs. 55 ± 5.4% hemolysis; p = 0.0001,
Fig. 1d). The osmolarity at which RBCs exhibited maximum
deformability (Osm Max) was lower for HbAS RBCs compared to
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Fig. 1. HbAS is associatedwith higher storage hemolysis in RBCs. Fresh leukoreduced human RBC units (n=3HbAA and n=9HbAS donors) processed and stored under standard blood
banking conditions and murine RBC units (n = 3 HbAA RBCs and n = 3 HbAS RBCs pooled samples, where each pooled sample contained RBCs from n= 11 mice) were stored at 4 °C,
sampled and tested at various times during a 42-day or 11-day storage period, respectively. (a,b) At the end of storage, there was a higher concentration of free hemoglobin in HbAS RBC
samples compared toHbAARBCs. (c,d)HbAS RBCs exhibited increased resilience under hypotonic-inducedosmotic shock compared toHbAARBCs throughout storage, asmeasuredby the
fraction of lysed RBCs in a hypotonic solution. (e,f) Human andmurine RBCs showed no difference at the end of storage undermechanical stress induced by agitationwith onemetal bead
(3/32″) for 180min in a 96-well plate. HbAA RBCs are indicated as red triangle and HbAS RBCs are indicated as black circle. HumanHbAA (h-HbAA), HumanHbAS (h-HbAS), Mouse HbAA
(m-HbAA), Mouse HbAS (m-HbAS). The results are presented as mean ± SEM. *p b 0.05; **p b 0.01; ****p b 0.0001 analyzed by 2Way ANOVA, GraphPad Prism 6.0.
241D.O. Osei-Hwedieh et al. / EBioMedicine 11 (2016) 239–248HbAA RBCs at the beginning and end of storage (Day 42, h-HbAS:
217.7 ± 0.5 vs. h-HbAA: 249.7 ± 1.2 mOsm), indicating that HbAS
RBCs are more dehydrated than HbAA RBCs and provides a possible ex-
planation for HbAS RBC resistance to hypotonic-induced osmotic stress
(Day 11, m-HbAS: 265.2 ± 6.0 vs. m-HbAA: 353.5 ± 5.6 mOsm) (Sup-
plemental Fig. S2, Fig. 1c–d). Human and murine HbAS RBCs did not
show increased hemolysis following mechanical stress compared with
HbAA RBCs (Fig. 1e–f). Taken together, the Berkeley murine HbAS
RBCs appear to show similar membrane properties to that of human
HbASRBCs during storage, suggesting that thesemice serve as a suitable
model of sickle cell trait for transfusion studies.3.2. Elevated Echinocyte Formation in HbAS RBCs Compared to HbAA RBCs
During Storage
Echinocyte formation occurs due to various factors such as cell dehy-
dration and ATP depletion, and has previously been used as a surrogate
marker for RBC storage integrity (Flatt et al., 2014). Human andmurine
RBCs were examined by scanning electron microscopy at the beginning
and end of 39–42 or 11-day storage, respectively. There were no differ-
ences in the percentage of echinocytes between h-HbAA and h-HbAS
RBCs or m-HbAA and m-HbAS RBCs at the beginning of storage but h-
HbAS RBCs showed higher percentage of echinocytes at the end of stor-
age compared to h-HbAARBCs (47.6% and 24.9%; p=0.0048, Fig. 2a–b).
A similar ﬁnding was observed in m-HbAS RBCs compared to m-HbAA
RBCs (68.8% and 41.4%, p b 0.0001, Fig. 2c–d).3.3. Stored HbAS RBCs Exhibit Accelerated 24 h Post-Transfusion Clearance
Compared to Stored HbAA RBCs
Next we sought to examine whether the increased storage hemoly-
sis and increased echinocyte formation of human andmouseHbAS RBCs
was indicative of accelerated aging that impacts post-transfusion sur-
vival. We established a murine model of allogeneic and xenogeneic
transfusion, using transfusion of DiI-labeled and DiD-labeled donor
RBCs (Hod et al., 2010b, Gilson et al., 2009, Hod et al., 2010a). There
was no signiﬁcant difference in the post-transfusion recovery of fresh
DiI-labeled h-HbAA and fresh DiD-labeled h-HbAS RBCs in mice at
24 h (Fig. 3a). Fresh h-HbAA and h-HbAS showed 100% and 78.9% sur-
vival in circulation 24 h post-transfusion, respectively. The N100%
post-transfusion survival of fresh HbAA RBCs at earlier time points is
due to incomplete distribution of transfused RBCs in the circulating
blood volume at the time of the initial tail vein blood sampling (Ti =
5 min post-transfusion). As Ti is arbitrarily deﬁned as 100% and all
subsequent time points are referenced to Ti, fresh HbAA transfused
RBCs, upon complete distribution, creates an artifact of N100%
survival in subsequent RBC recovery estimations given their negligible
loss in circulation. This artifact has been previously reported in red
cell survival post-transfusion studies (Franco et al., 2000, Mock et al.,
1999). After 39–42 day storage, the mean 24 h post-transfusion
survival was 71.6 ± 19.5% for stored h-HbAA and 4.3 ± 4.9% for
stored h-HbAS RBCs (Fig. 3b). Consistent with human RBCs, stored
m-HbAS RBCs showed accelerated clearance from circulation compared
with stored m-HbAA RBCs, whereas no differences were noted in
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Fig. 2. Echinocyte formation is increased in HbAS RBCs compared to HbAA RBCs during storage. RBC images were taken with a JEOL JSM- 6335F scanning electron microscope. (a) Upper
panel shows representative ﬁelds from fresh and stored human HbAA and HbAS RBCs at the beginning and the end of 39–42 day storage. (b) Five ﬁelds per sample were counted and
analyzed from one healthy and one SCT representative donors at the beginning and end of storage. Human and mouse RBC SEM analysis was performed twice. (c) Lower panel shows
representative ﬁelds from fresh and 11-day stored murine RBCs obtained fromWT C57BL/6 and Berkeley hemizygous mice (One pooled sample each where n= 11 mice donor RBCs/
pooled sample). (d) Six ﬁelds were counted and analyzed for echinocyte formation from each pooled sample. The results are presented as mean ± SEM, where echinocyte formation
represents % echinocyte per total number of cells in ﬁelds counted. **p b 0.01; ****p b 0.0001 analyzed by 2Way ANOVA, GraphPad Prism 6.0.
242 D.O. Osei-Hwedieh et al. / EBioMedicine 11 (2016) 239–248post-transfusion recovery of fresh m-HbAS and fresh m-HbAA RBCs
(Fig. 3c–d).
The high 24 h post-transfusion survival of fresh human and murine
HbAA or HbAS in recipient mice underscore the lack of an immune-
mediated clearance of transfused RBCs. The ﬁndings conﬁrm previous
reports indicating the absence of anti-major histocompatibility complex
antibodies responsible for the clearance of incompatible red cells in
mice, and suggest that the rapid clearance of human and murine HbAS
RBCs is due to storage-dependent changes and not alloantibody-
mediated RBC clearance (Stimpﬂing et al., 1976; Hod et al., 2010a;
Ong and Mattes, 1989) (Rice and Crowson, 1950). To ensure that label-
ing dyes did not signiﬁcantly impact RBC clearance, C57BL/B6 mice ex-
pressing GFPwere transfused with unlabeledm-HbAA orm-HbAS RBCs
(Supplemental Fig. S3). No differences were observed in the post-trans-
fusion survival when fresh unlabeled m-HbAA and m-HbAS RBCs were
transfused into separate groups of mice expressing GFP (Supplemental
Figs. S3C, S4), whilewe again observed that the transfusion of unlabeled
stored and agedm-HbAS RBCs showed accelerated clearance compared
to unlabeled stored and aged m-HbAA RBCs (Supplemental Fig. S3D).Furthermore, there was no difference in the post-transfusion survival
of stored human RBCs following 39–41 day storage in standard plasti-
cizer bags or in glass (Supplemental Fig. S5) suggesting that HbAS RBC
in vivo behavior following storage was not due to speciﬁc storage con-
ditions. The post-transfusion clearance of stored human and murine
RBCs show a bi-phasic curve with rapid disappearance of both HbAA
and HbAS RBCs within 2 h post-transfusion, followed by slower rate of
disappearance where HbAS RBCs exhibited two-fold rate of disappear-
ance (rate of disappearance per hour, h-HbAS: 31.8% and h-HbAA:
12.6%; p= 0.0043) (Fig. 3b) and (m-HbAS: 24.5% versus m-HbAA RBC
13.8% p= 0.0022) at 2 h (Fig. 3d).
3.4. Clodronate Treatment or Splenectomy Does Not Alter Stored HbAS RBC
24 h Post-Transfusion Survival
To determine whether stored HbAS RBCs are preferentially cleared
by the mononuclear phagocyte system, we depleted F4/80+ macro-
phages in the liver and spleen using liposomal clodronate prior to
transfusion. Intraperitoneal administration of liposomal clodronate
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Fig. 3. Stored human andmurine HbAS RBCs show accelerated post-transfusion clearance compared to stored HbAA RBCs. (a)WT C57BL/6 recipient mice (n=6)were transfused with a
50:50mixture of freshDiI-labeled h-HbAARBCs (indicated as red triangle) and freshDiD-labeled h-HbASRBCs (indicated as black circle). (b)N=9WTC57BL/6 recipientswere transfused
with a 50:50 mixture of 39-day stored DiI-labeled h-HbAA RBCs (indicated as blue circle) and stored DiD-labeled h-HbAS RBCs (indicated as green square) both re-suspended to a 55%
hematocrit following labeling. (c) WT C57BL/6 mice recipients (n = 6) were transfused with a 50:50 mixture of fresh DiI-labeled m-HbAA RBCs (indicated as red triangle) and fresh
DiD-labeled m-HbAS RBCs (indicated as black circle). (d) WT recipient mice (n= 6) were transfused with 11-day stored DiI-labeled m-HbAA RBCs (indicated as blue circle) and DiD-
labeled stored m-HbAS RBCs (indicated as green square). All mice were 8–12 weeks of age and received a total volume of 200 μl of leukoreduced HbAA and HbAS RBCs (100 μl each).
To mimic similar conditions, human and murine RBCs were stored in glass. Post-transfusion recovery was measured by dual-label cell tracking by ﬂow cytometry unless stated
otherwise. The results are presented as mean ± SD. *p b 0.05; ***p b 0.001; ****p b 0.0001 analyzed by 2Way ANOVA, GraphPad Prism 6.0.
243D.O. Osei-Hwedieh et al. / EBioMedicine 11 (2016) 239–248effectively depleted F4/80+ macrophages in both the liver and spleen,
with N85% depletion of splenic F4/80+ macrophages 24 h post-treat-
ment (Fig. 4a, b). We show clodronate depletion of macrophages en-
hances early post-transfusion survival of stored m-HbAA RBCs as
previously shown but not stored m-HbAS RBCs (Fig. 4c–d, S6A–
B)(Hod et al., 2010b). We next performed surgical splenectomies and
survived mice for 5 days until stable for transfusion studies, we found
that consistent with the RBC post-transfusion survival studies in
splenectomizedmice (Fig. 4d), splenectomy did not alter tissue seques-
tration of stored m-HbAS RBCs within the kidneys and livers following
transfusion (Fig. 5a–b). Taken together, these ﬁndings suggest that the
mechanism of reduced post-transfusion survival of stored m-HbAS
RBCs is different from that of stored m-HbAA RBCs where macrophage-
and spleen-mediated clearance mechanisms may play a predominant
role.
We further investigated whether intravascular hemolysis contrib-
utes to the reduced post-transfusion recovery of stored m-HbAS RBCs.
Transfused mice recipients were assayed for plasma and urinary free
hemoglobin at various time intervals. Recipient mice transfused with
stored m-HbAS RBCs did not show higher levels of plasma or urinary
free hemoglobin levels at 5 min and 4 h post-transfusion compared
with mouse recipients transfused with m-HbAA RBCs (SupplementalFig. S7), indicating that intravascular hemolysis did not contribute sig-
niﬁcantly to the reduced post-transfusion recovery of m-HbAS RBCs.
3.5. Increased Sequestration of Stored HbAS RBCs Within Kidney, Liver and
Spleen Following Transfusion
To evaluatewhether storedHbAS andHbAA RBC showdifferences in
tissue entrapment following transfusion and provide an explanation for
the rapid clearance of stored m-HbAS RBCs in intact WT recipient mice,
we transfused cy3-labeled stored m-HbAA or m-HbAS RBCs and har-
vested kidney, liver and spleen of recipient mice 2 h post-transfusion
for confocal imaging and quantitative analysis (Figs. 6 and 7). There
was higher sequestration of stored m-HbAS RBCs within the recipient
kidney, liver and spleen when compared to recipients transfused with
m-HbAA RBCs (Fig. 6a and b). When stored h-HbAS and h-HbAA RBCs
were transfused into murine recipients, h-HbAS RBCs were entrapped
in the spleen to a greater extent than h-HbAA RBCs (Fig. 7a–b), presum-
ably due to the narrower internal diameter of splenic sinusoidal vessels
(Schroit et al., 1984; Mebius and Kraal, 2005; Connor et al., 1994). Col-
lectively, these ﬁndings indicate that enhancedmechanical entrapment
in tissue accounts for the rapid clearance of transfused HbAS RBCs from
circulation of intact mice. It remains unclear why splenectomy did not
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Fig. 4. Clodronate treatment or splenectomy does not alter storedm-HbAS RBC post-transfusion survival. (a)WT recipient mice were treatedwith clodronate or PBS liposomes 24 h prior
to liver and spleen harvest for immunohistochemistry. Representative images are shown indicating staining for F4/80+ macrophages. (b) WT mice received either clodronate, PBS
liposomes or no treatment. Mice were euthanized after 24 h. Spleens were homogenized and stained with F4/80 and CD11b antibodies. Samples were analyzed using ﬂow cytometry
to quantify the F4/80+ population. (c) WT recipient mice were transfused with 11-day stored m-HbAS RBCs 24 h following clodronate (n = 3) or PBS liposome (n = 3) injection
(2 mg i.p.). (d) WT recipient mice were transfused with 11-day stored m-HbAS RBCs 5 d following splenectomy (n= 4) or sham procedure (n= 6) Results presented are mean ± SD.
244 D.O. Osei-Hwedieh et al. / EBioMedicine 11 (2016) 239–248improve RBC recovery in the circulation since this appears to be amajor
site of RBC entrapment. This may reﬂect the propensity of HbAS RBCs to
entrap in the liver, kidney and other organs (Fig. 6a–b).
4. Discussion
The main ﬁndings of this study are that both human and murine
HbAS RBCs show accelerated storage-related aging and reduced post-
transfusion survival after prolonged cold storage compared to HbAA
RBCs. There was no difference in the post-transfusion recovery of
fresh murine and human HbAA and HbAS RBCs when transfused into
wild type C57Bl/6 mouse recipients, suggesting accelerated storage-induced aging of HbAS RBCs. Our ﬁndings indicate that enhanced me-
chanical entrapment in the kidney, liver and spleen account for the
rapid clearance of stored m-HbAS RBCs following transfusion, an obser-
vation possibly consistentwith rare clinical observations of organ injury
in sickle cell trait individuals (Rice and Crowson, 1950).
To date, over 1000 mutations in the human genome relate to the
evolved response to endemic malaria infection, with sickle cell trait
being one of the most common mutations that confers protection
against this endemic parasite (Hedrick, 2011; Jallow et al., 2009). It
still remains to be determined whether other hemoglobinopathies, car-
rier status of alpha thalassemia, and glucose-6-phospate dehydrogenase
(G6PD) deﬁciency that occur with high frequency in African Americans
ab
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Fig. 5. Splenectomy does not increase kidney and liver sequestration of stored m-HbAS
RBCs following transfusion. Splenectomized WT C57BL/6 recipient mice (n = 7) or
sham operated (n = 5) were transfused with stored m-HbAS RBCs. Kidney and liver
organs were harvested 2 h post-transfusion, ﬁxed in 2% PFA and processed for confocal
imaging. (a) Confocal images showing sequestered m-HbAS RBCs in recipient mouse
tissues (Magniﬁcation 20×, Green: phalloidin, Blue: DAPI, Red: Cy3-labeled m-HbAS
RBCs). (b) Individual points represent sequestered m-HbAS RBCs normalized to nuclei
number per section quantiﬁed by ﬂuorescence intensity using NIS Elements. Two
sections from each recipient mouse organ were analyzed.
245D.O. Osei-Hwedieh et al. / EBioMedicine 11 (2016) 239–248and populations originally from malaria endemic regions, exhibit simi-
lar behavior as sickle cell trait during storage and following transfusion.
This is particularly important because these populations represent a
donor pool fromwhich sickle cell disease patients are likely to be trans-
fused to reduce the risk of RBC allo-immunization. Carriers of these
mutations usually do not present with clinical symptoms, however, as
shown in this study, prolonged exposure of RBCs to storage-induced
stress may unmask subtle perturbations of the heterozygous state.
Our data support previous studies showing no difference in the stor-
age hemolysis of h-HbAA and h-HbAS RBCs at earlier time-points (up to
21 days) (Levin and Truax, 1960; Ray et al., 1959). However, after
28 days, this accumulation intensiﬁes in h-HbAS RBC units. These stud-
ies suggest a need to re-evaluate the suitability of HbAS RBCs for trans-
fusion after prolonged storage since prior studies only examined RBCs
thatwere stored for shorter periods (b21days) of time in ACD anticoag-
ulant and utilized less precise methods to assess RBC post-transfusionsurvival. In this controlled study, we utilize highly sensitive tracking
methods in examining the storage integrity and post-transfusion sur-
vival of h-HbAS RBCs at the limits of the current approved storage
time of 42 days. The relevance of this study is underscored by the obser-
vation that fresh h-HbAA and h-HbAS RBCs exhibit a high post-transfu-
sion survival and only show decreased post-transfusion survival in wild
type C57Bl/6mice following storage, which cannot be explained byme-
chanical restraints due to the larger diameter of human RBCs compared
to murine RBCs, since even stored h-HbAA RBCs still exhibit high post-
transfusion survival.
There are no comprehensive studies evaluating clearance of human
RBCs in immunocompetent mice. Prior studies utilized NOD-scid mice
for xenotransfusion of human RBCs based upon an assumption that
xenotransfusion in immunocompetent mice would induce rapid im-
mune-mediated clearance of human RBCs (Bazin et al., 2002; Moore
et al., 1995). However, even in NOD-scid mice, fresh human RBCs
showed signiﬁcant clearance over theﬁrst 4 h, arguing against clearance
by cross-reactive anti-hRBC antibodies as NOD-scidmice lack such anti-
bodies (Moore et al., 1995; Bazin et al., 2002). It is also unlikely that
cross-species differences in RBCs induce rapid alternative comple-
ment-mediated lysis of h-RBC in mice, as mouse complement fails to
lyse human RBCs (Ish et al., 1993). In contrast, we observe near 100%
post-transfusion recovery of fresh human AA RBCs transfused into im-
munocompetent C57Bl/6 mice. This discrepancy may be related to dif-
ferences in the labeling method of transfused RBCs, as prior studies
utilized chromium-labeling as an in vivo tracking method (Bazin et al.,
2002). Chromium binds to hemoglobin but it is possible that chromium
may elute from transfused human hemoglobin and result in the
artefactual appearance of rapid RBC clearance (Awwad et al., 1966;
Gimlette, 1978).We utilized a lipophilic ﬂuorescent dye that directly in-
tercalates with the RBC membrane.
To prevent the negative impact of hemolysis, the U.S. Food and Drug
Administration set the upper threshold of hemolysis in a RBC unit to be
transfused at 1% but some RBC units stored under standard blood bank-
ing conditions fail to meet this requirement due to factors that may be
donor speciﬁc (Mishler et al., 1979; Dumont and AuBuchon, 2008).
The human HbAS RBCs purchased from a commercial blood bank for
this study would not have met the regulatory requirement near the
end of the FDA accepted shelf-life of 42 days, as these units exhibited
a hemolysis level of N1%. Other occult genetic mutations such as sickle
cell trait that increase storage hemolysis may explain why some RBCs
age faster during storage.
The enhanced tissue sequestration of HbAS RBCs that we observed
may be due to reduced deformability of HbAS RBC membrane that
worsens during storage and increases the propensity for microvascular
obstruction. However, splenectomy of recipient mice did not alter post-
transfusion recovery of stored m-HbAS RBC. This observation is likely
due to the fact that the liver is signiﬁcantly larger and about ten times
the spleen weight in mice, so that increases in circulating RBCs after
splenectomy are not measurable (Sisto et al., 2003). The limitation in
our technique to fully quantify the capacity of the liver to entrap and
clear large numbers of stored RBCs in real time may account for the
lack of observable differences.
One limitation of this study and previous studies utilizing murine
RBCs to study the effect of storage lesion on RBC post-transfusion sur-
vival is the number ofmice that are needed to obtain sufﬁcient volumes
(~75 ml) for conventional storage in pediatric transfer bags with
diethylhexyl phthalate (DEHP). It has also been shown that storage in
pediatric transfer bags increases RBC hemolysis and alters osmotic fra-
gility (Kanias et al., 2013). These considerations demonstrate the practi-
cal challenges of an acceptable storage model to mimic RBC behavior in
standard-sized blood bags. Of note, studies performed decades ago to
determine the transfusion suitability of stored h-HbAS RBCs were not
under current approved conditions (Levin and Truax, 1960; Ray et al.,
1959). Nonetheless,murineRBCs stored under similar conditions exhib-
ited progressive reduction in 24 h post-transfusion survival with 64%
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Fig. 6. Increased tissue sequestration of stored m-HbAS RBCs within kidney, liver and spleen organs following transfusion when compared with stored m-HbAA RBCs. WT C57BL/6
recipient mice (n= 5 per group) were transfused with stored cy3 labeled m-HbAA or m-HbAS RBCs. Kidney, liver and spleen organs were harvested 2 h post-transfusion for confocal
imaging. (a) Confocal images showing sequestered m-HbAA and m-HbAS RBCs in recipient mouse tissues (Magniﬁcation 20×, Green: phalloidin, Blue: DAPI, Red: cy3 RBCs). (b)
Individual points represent sequestered cy3-labeled RBCs normalized to nuclei number per section quantiﬁed by ﬂuorescence intensity using NIS Elements. Two sections from each
recipient mouse organ were analyzed (n= 10 sections per group). Statistical Analysis by two-tailed Mann Whitney U, *p b 0.05, **p b 0.01, lines indicate the median.
246 D.O. Osei-Hwedieh et al. / EBioMedicine 11 (2016) 239–248post-transfusion survival following 14-day storage as well as
phosphatidylserine externalization and reduced CD47 expression simi-
lar to trends observed in human RBCs at the end of 42-day storage
(Gilson et al., 2009).
In conclusion, HbAS RBCs harbor subtle differences inmembrane re-
sistance to osmotic stress, show accelerated degradation during
prolonged storage, and reduced survival in circulation following trans-
fusion. It remains unknown whether our ﬁndings of impaired transfu-
sion recovery of both murine and human HbAS in mice reﬂect that of
stored human HbAS red cells in humans. Nevertheless, these ﬁndings
suggest that further investigation should be performed to determine a
shorter length of allowable storage to improve the efﬁcacy of stored
HbAS RBCs and post-transfusion recovery in humans.
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